Position in NVAX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,617,818
+$402,924 QoQ
Shares Held
277,900
+2.1% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 263 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. NVAX ranks #94 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,617,818 | 277,900 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,214,894 | 272,100 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,828,512 | 272,100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,450,142 | 282,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,743,210 | 276,700 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,790,313 | 279,300 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,278,536 | 283,400 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,129,714 | 247,800 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,137,148 | 247,800 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,008,580 | 211,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $864,960 | 180,200 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,304,648 | 180,200 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,393,868 | 187,600 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,174,635 | 169,500 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,941,892 | 188,900 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,372,460 | 185,300 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $9,247,114 | 179,800 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $22,912,515 | 311,100 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $38,485,830 | 269,000 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $57,735,835 | 278,500 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $60,741,891 | 286,100 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $26,362,474 | 145,400 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $15,444,135 | 138,500 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $14,237,190 | 131,400 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $9,585,250 | 115,000 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||